SK Boston Consulting Group Matrix

SK Telecom's AI Data Center (AIDC) business is a significant growth engine, already surpassing KRW 100 billion in quarterly revenue. This segment saw an 11.1% year-on-year revenue increase in Q1 2025, highlighting its robust expansion.

The company has ambitious plans, targeting KRW 1 trillion in annual AIDC revenue by 2030. This aggressive target underscores the immense potential of the AI infrastructure market and SK's strategic positioning within it.

The AIDC business is vital for powering the rapidly evolving AI industry. Its growth directly correlates with the increasing demand for advanced computing power and specialized data handling, making it a cornerstone of SK Telecom's future strategy.

SK Hynix's significant lead in HBM technology, crucial for AI, positions it as a Star. Its market share gains in DRAM, driven by HBM, and sold-out production for 2025 highlight its exceptional growth trajectory.

SK Biopharmaceuticals' Xcopri is a Star in the epilepsy market, with strong US adoption and projected revenue exceeding W1 trillion by 2028. Expanded marketing and new indications further solidify its leading position.

SK Telecom's AI Data Center (AIDC) business is a Star, already generating over KRW 100 billion quarterly and targeting KRW 1 trillion annually by 2030. This growth is fueled by the increasing demand for AI infrastructure.

SK Telecom's AI Transformation (AIX) Solutions are also Stars, showing robust revenue growth with Q2 2025 at KRW 46.8 billion (up 15.3% YoY) and Q1 2025 at KRW 45.2 billion (up 27.2% YoY), underpinning its global AI strategy.

SK On, while facing initial losses, is a Star in the high-growth EV battery sector. Its planned capacity expansions in the US and China for 2025, coupled with BlueOval SK's 2024 production start, position it for significant future gains in the North American market.

SK Inc. C&C, a key player in IT services and digital platforms, including cloud, ESG, and digital factory solutions, consistently delivers stable revenue. Its role as the IT operational arm for the SK Group holding company allows it to tap into a strong client base and deep expertise, ensuring a steady stream of cash flow.

The company's strategic focus on integrating AI into its enterprise solutions further solidifies its position. This segment's maturity and the indispensable nature of its offerings are the primary drivers behind its classification as a cash cow within the SK BCG Matrix.

SK Innovation's petrochemical division is a prime example of a cash cow, consistently generating substantial profits from its established refining and chemical operations. Despite the cyclical nature of the industry, its significant market share and operational efficiency ensure a reliable cash flow, crucial for funding new ventures. In 2023, SK Innovation's petrochemical segment reported an operating profit of KRW 1.6 trillion, underscoring its robust performance.

SK E&S's liquefied natural gas (LNG) business serves as a significant cash cow, benefiting from stable demand and long-term contracts. The company's strategic investments in LNG infrastructure and its position as a leading LNG importer in South Korea solidify its market dominance. As of the first half of 2025, SK E&S's LNG sales volume reached 5.2 million tons, contributing KRW 2.1 trillion in revenue.

SK Bioscience's vaccine manufacturing business, while facing evolving market dynamics, continues to represent a mature and stable revenue stream, acting as a cash cow. Its established production capabilities and ongoing partnerships provide a predictable income. In 2024, the company secured a KRW 300 billion contract for vaccine production, demonstrating continued demand for its established services.

Certain traditional chemical or materials businesses within SK Inc.'s portfolio, though not explicitly labeled as 'dogs' in recent public disclosures, may exhibit characteristics of this category. These could be older product lines with declining demand due to shifts in consumer preferences or technological advancements, leading to low growth and market share.

SK's strategic emphasis on high-growth sectors like advanced materials, semiconductors, and green solutions signals a potential divestment or reduced investment in less competitive or future-oriented conventional chemical segments. For instance, if a legacy petrochemical product line faces intensifying competition from more sustainable alternatives, it could be considered a 'dog' if it lacks a clear path to revitalization or differentiation.

While specific financial figures for individual 'dog' segments are typically not broken out, SK Inc.'s overall revenue for its chemical business segment in 2023 was approximately KRW 12.4 trillion, with performance varying across its diverse product offerings. Segments experiencing margin pressure or stagnant volume growth due to these 'dog' characteristics would contribute to a less favorable overall divisional performance.

In the SK BCG Matrix framework, "Dogs" represent business units or investments with low market share and low growth potential. These are typically underperforming assets that consume resources without generating significant returns.

SK Group's strategy involves identifying and managing these "Dog" assets, often through divestment or restructuring, to reallocate capital towards more promising ventures. This proactive approach is crucial for maintaining overall portfolio health and driving future growth.

While not explicitly categorized as 'Dogs' in public reports, certain legacy businesses within SK's diverse portfolio, particularly in traditional chemical sectors, may exhibit these characteristics. If these segments face declining demand or intense competition without a clear path to innovation, they would align with the 'Dog' profile.

SK Inc.'s chemical segment revenue was approximately KRW 12.4 trillion in 2023, with performance varying across its product lines. Segments experiencing margin pressure or stagnant volume growth due to 'Dog' characteristics would negatively impact the overall divisional performance.

SK Innovation E&S is actively pivoting towards becoming a global clean energy leader, broadening its portfolio to include hydrogen, offshore and onshore wind, solar, and Energy Storage Systems (ESS). This strategic expansion into diverse renewable sectors signals a commitment to future energy demands.

The company's investment in the Incheon hydrogen liquefaction plant, which began commercial operations in 2024, underscores its focus on the burgeoning hydrogen market. While this represents a high-growth area, SK is still in the process of building a substantial market presence within this developing sector.

Question Marks represent business units or products with low relative market share in a high-growth market. These ventures require significant investment to increase market share and potentially become Stars. SK's strategy involves careful resource allocation to nurture these promising but currently underdeveloped areas.

The core challenge for Question Marks is to transition them into Stars by investing in growth and market development. Without sufficient investment, they risk remaining Question Marks or declining into Dogs. SK's approach focuses on identifying which Question Marks have the highest potential for future success.

SK's investment in areas like Generative AI and Web3, as well as early-stage biopharmaceutical pipelines, clearly aligns with the characteristics of Question Marks. These are high-growth markets where SK is still establishing its presence and market share.